Pharma-Bio Serv (PBSV) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to -$10.9 million.
- Pharma-Bio Serv's Enterprise Value rose 1483.56% to -$10.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$10.9 million, marking a year-over-year increase of 1483.56%. This contributed to the annual value of -$10.9 million for FY2025, which is 1483.56% up from last year.
- According to the latest figures from Q4 2025, Pharma-Bio Serv's Enterprise Value is -$10.9 million, which was up 1483.56% from -$10.7 million recorded in Q3 2025.
- In the past 5 years, Pharma-Bio Serv's Enterprise Value registered a high of -$10.4 million during Q2 2025, and its lowest value of -$19.0 million during Q1 2021.
- In the last 5 years, Pharma-Bio Serv's Enterprise Value had a median value of -$14.4 million in 2022 and averaged -$14.2 million.
- As far as peak fluctuations go, Pharma-Bio Serv's Enterprise Value tumbled by 2447.49% in 2021, and later surged by 2274.59% in 2025.
- Over the past 5 years, Pharma-Bio Serv's Enterprise Value (Quarter) stood at -$17.5 million in 2021, then grew by 17.21% to -$14.5 million in 2022, then decreased by 3.56% to -$15.0 million in 2023, then rose by 14.9% to -$12.7 million in 2024, then rose by 14.84% to -$10.9 million in 2025.
- Its last three reported values are -$10.9 million in Q4 2025, -$10.7 million for Q3 2025, and -$10.4 million during Q2 2025.